LifeWatch Services has acquired FlexLife Health, according to a press realease. FlexLife offers patients remote services to monitor and measure coagulation.
FlexLife was founded in 2012 by the Cleveland Clinic Foundation and ZIN Technologies, (a NASA partner for health in space) to offer home monitoring solutions for international normalised ratio (INR) measurement. FlexLife offers INR monitoring services via a proprietary web-based digital health platform which, it claims, is superior to all other current service offerings in the market.
LifeWatch’s electrophysiologist and cardiologist relationship base have already expressed a deep interest in remote monitoring of INR for their patients, according to a press release. Stephan Rietiker, CEO of LifeWatch, states, “The FlexLife product complements well our existing cardiac monitoring business and will allow us to provide doctors and their patients needing INR therapy due to atrial arrhythmias with a unique and easy-to-use product that will improve patient quality of life.”
LifeWatch expects to commence activities already in December this year with a full launch in the US at the beginning of 2016.
